Robert F. Grover

5.6k citations

84 papers · 3.9k indexed · 2 hit papers · h-index 32

Genetics top 1%
Pulmonary and Respiratory Medicine top 2%
Endocrine and Autonomic Systems top 0.5%
Physiology top 5%
Cardiology and Cardiovascular Medicine top 2%

Co-authors: John Τ. Reeves John V. Weil S.Gilbert Blount Giles F. Filley E. Byrne-Quinn I. E. Sodal John H.K. Vogel L. Howard Hartley
Topics: High Altitude and Hypoxia (36 papers)Neuroscience of respiration and sleep (21 papers)Pulmonary Hypertension Research and Treatments (14 papers)
Cited by: Endocrine and Autonomic Systems Genetics Critical Care and Intensive Care Medicine
Journals: New England Journal of Medicine Circulation Journal of Clinical Investigation
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Robert F. Grover

82 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

2004 579 citations Ángel Crespo López, José A. Lorente et al. Critical Care Medicine profile →
Hypoxic ventilatory drive in normal man

1970 324 citations John V. Weil, Robert F. Grover et al. profile →

Peers

Countries citing papers authored by Robert F. Grover

Since Specialization

Citations

This map shows the geographic impact of Robert F. Grover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Grover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Grover more than expected).

Fields of papers citing papers by Robert F. Grover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Grover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Grover. The network helps show where Robert F. Grover may publish in the future.

Co-authorship network of co-authors of Robert F. Grover

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Grover. A scholar is included among the top collaborators of Robert F. Grover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Grover. Robert F. Grover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2018 Mars Insight Trajectory Reconstruction and Performance from Launch Through Landing 2019 ·(unknown),(unknown),(unknown),Eugene Bonfiglio,Robert F. Grover,(unknown),(unknown),Eric Gustafson,(unknown),D. Jefferson,E. L. Lau,(unknown),(unknown),(unknown),(unknown),(unknown),Mark Wallace	4
2	Jack Reeves and his science 2005 ·Respiratory Physiology & Neurobiology ·Lorna G. Moore,Robert F. Grover	1
3	Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* 2004 ·Critical Care Medicine ·David I. Watson,Robert F. Grover,Antonio Anzueto,José A. Lorente,Mark Smithies,Rinaldo Bellomo,Kalpalatha K. Guntupalli,Steven H. Grossman,Jill Donaldson,(unknown)	94
4	Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shockbreakdown → 2004 ·Critical Care Medicine* ·Ángel Crespo López,José A. Lorente,Jay S. Steingrub,Jan Bakker,Angela McLuckie,Sheila M. Willatts,Michael Brockway,Antonio Anzueto,Laurent Holzapfel,(unknown),Michael Silverman,Jukka Takala,Jill Donaldson,Carl Arneson,G.Richard Grove,Steven H. Grossman,Robert F. Grover	579
5	Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* 2004 ·Critical Care Medicine ·Jan Bakker,Robert F. Grover,Angela McLuckie,Laurent Holzapfel,Jan Andersson,Robert F. Lodato,David I. Watson,Steven H. Grossman,Jill Donaldson,Jukka Takala	140
6	Exercise-dependent ventilatory sensitivity to hypoxia in Andean natives 2002 ·Respiratory Physiology & Neurobiology ·Robert F. Grover,César De la Cruz Valencia,(unknown),John Τ. Reeves	2
7	A randomized, double‐blind, placebo‐controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis 2001 ·Veterinary Dermatology ·(unknown),Sheila M. F. Torres,Kim Horne,Robert F. Grover,(unknown)	25
8	Norepinephrine and NG-monomethyl-l-arginine in hyperdynamic septic shock in pigs: Effects on intestinal oxygen exchange and energy balance 2000 ·Critical Care Medicine ·Karl Träger,Peter Radermacher,Karen M. Rieger,Robert F. Grover,Arnim Vlatten,Thomas Iber,(unknown),Michael Georgieff,B. Šantak	15
9	An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock 1999 ·Critical Care Medicine ·Robert F. Grover,David Zaccardelli,Gene Colice,Kalpalatha K. Guntupalli,David I. Watson,Jean‐Louis Vincent	134
10	Norepinephrine and N ω-Monomethyl- l -arginine in Porcine Septic Shock: Effects on Hepatic O2 Exchange and Energy Balance 1999 ·American Journal of Respiratory and Critical Care Medicine ·Karl Träger,Peter Radermacher,Karen M. Rieger,Arnim Vlatten,J. Vogt,Thomas Iber,(unknown),Ulrich Wachter,Robert F. Grover,Michael Georgieff,B. Šantak	26
11	Increased Wedge Pressure Facilitates Decreased Lung Vascular Resistance during Upright Exercise 1988 ·CHEST Journal ·John Τ. Reeves,Richard E. Moon,Robert F. Grover,Bertron Μ. Groves	19
12	Cardiovascular adjustments to various degrees of acute isocapnic hypoxia in dogs 1984 ·American Journal of Veterinary Research ·Alan Tucker,Robert F. Grover,John Τ. Reeves	2
13	Excessive Polycythemia of High Altitude: Role of Ventilatory Drive and Lung Disease ^1– ³ 1978 ·American Review of Respiratory Disease ·Meir H. Kryger,Robert E. McCullough,Robert C. Doekel,(unknown),John V. Weil,Robert F. Grover	49
14	Oxygen-tension-dependent pulmonary vascular responses to vasoactive agents 1977 ·Canadian Journal of Physiology and Pharmacology ·Alan Tucker,Ε. Kenneth Weir,Robert F. Grover,John Τ. Reeves	15
15	Pulmonary microembolism: Attenuated pulmonary vasoconstriction with prostaglandin inhibitors and antihistamines 1976 ·Prostaglandins ·Alan Tucker,Ε. Kenneth Weir,John Τ. Reeves,Robert F. Grover	21
16	Abnormal Circulatory Responses to High Altitude in Subjects with a Previous History of High-Altitude Pulmonary Edema 1971 ·Circulation ·Herbert N. Hultgren,Robert F. Grover,L. Howard Hartley	153
17	Reversal of high altitude pulmonary hypertension 1966 ·The American Journal of Cardiology ·Robert F. Grover,John H.K. Vogel,(unknown),S.Gilbert Blount	53
18	SECONDARY POLYCYTHEMIA IN ADOLESCENTS AT HIGH ALTITUDE. 1965 ·PubMed ·(unknown),David B. Shaw,Robert F. Grover	13
19	Pulmonary hypertension. Individual and species variability relative to vascular reactivity 1963 ·American Heart Journal ·Robert F. Grover,John H.K. Vogel,Keith H. Averill,S.Gilbert Blount	90
20	Effect of Hyperventilation, Hypothermia, and Urea on Circulation and Cerebrospinal Fluid Pressure in the Dog 1963 ·Anesthesiology ·(unknown),Robert F. Grover,(unknown),robert virtue	3

About Robert F. Grover

Robert F. Grover is a scholar working on Endocrine and Autonomic Systems, Genetics and Complementary and alternative medicine, having authored 84 papers that have together received 3.9k indexed citations. Recurring topics across this work include High Altitude and Hypoxia (36 papers), Neuroscience of respiration and sleep (21 papers) and Pulmonary Hypertension Research and Treatments (14 papers). The work is most often cited by research in Endocrine and Autonomic Systems (968 citations), Genetics (1.4k citations) and Critical Care and Intensive Care Medicine (239 citations). Robert F. Grover has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include John Τ. Reeves, John V. Weil, S.Gilbert Blount, Giles F. Filley, E. Byrne-Quinn, I. E. Sodal, John H.K. Vogel, L. Howard Hartley, Steven H. Grossman and Jan Bakker. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact